Abstract:Background and objective: The cysteine protease cathepsin K is elevated in both human and animal models of heart failure. Global deletion of cathepsin K attenuates both high fat diet- and pressure overload-induced cardiac hypertrophy and contractile dysfunction, although the role of cardiac cathepsin K remains unclear. To this end, the objective of this study was to generate a cardiomyocyte-specific knockout of cathepsin K ( Ctsk -/- ) and to test the hypothesis that deletion of cardiac cathepsin K protects against doxorubicin-induced cardiotoxicity. Methods: Ctsk -/- mice were generated by Ctsk targeted trap-allele including both FLP-FRT and Cre-lox systems. Cre-recombinase in myosin-heavy chain-Cre transgenic mice recognizes LoxP sites in “floxed (flanked by LoxP)” mice, and deletes the exons from 2 to 5 of Ctsk . Protein and mRNA levels of Ctsk and exon 2 were determined by Western blot and quantitative RT-PCR respectively. Four-months-old control (fl/fl-Cre - ) and Ctsk -/- (fl/fl-Cre + ) mice received two injections of doxorubicin (10mg/kg, i.p. at 3-day intervals, 20mg/kg cumulative), one week following which, body and tissue weight, echocardiographic properties, cardiomyocyte contractile function and Ca 2+ -handling were evaluated. Results: Cathepsin K mRNA and protein were attenuated by over 80% in the hearts of the knockout mice compared to the control. Doxorubicin injections resulted in an increase in total heart mass and the length of individual cardiomyocytes. Furthermore, doxorubicin-treated mice exhibited cardiomyocyte contractile dysfunction, characterized by depressed peak-shortening, maximal velocity of shortening and re-lengthening, and impaired intracellular Ca 2+ homeostasis. Additionally, mice receiving doxorubicin exhibited significant increases in end-systolic and end-diastolic diameters and decreased fractional shortening and wall thickness. These deleterious cardiac effects of doxorubicin were significantly attenuated or reversed in mice lacking cardiac cathepsin K. Conclusion: Mitigation of doxorubicin-induced cardiac anomalies by targeted deletion of cardiac cathepsin K suggests that cathepsin K represents a novel, bona-fide, pharmacological target for cardiac toxicity and complications.

Cathepsin K knockout alleviates aging-induced cardiac dysfunction.

Cathepsin K Knockout Mitigates High-Fat Diet–Induced Cardiac Hypertrophy and Contractile Dysfunction

Cardiac Overexpression of Antioxidant Catalase Attenuates Aging-Induced Cardiomyocyte Relaxation Dysfunction

CARDIAC‐SPECIFIC OVEREXPRESSION OF CATALASE PROLONGS LIFESPAN AND ATTENUATES AGEING‐INDUCED CARDIOMYOCYTE CONTRACTILE DYSFUNCTION AND PROTEIN DAMAGE

Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy.

Cardiomyocyte-specific Disruption of Cathepsin K Protects Against Doxorubicin-Induced Cardiotoxicity

Cardiomyocyte-Specific Deletion of Cathepsin K Protects Against Doxorubicin-Induced Cardiac Dysfunction

Abstract 10153: SIRT1 Activation Restores Cardioprotection in the Aged Heart Against Ischemia/Reperfusion Injury

Kielin/chordin-like protein deficiency causes cardiac aging in male mice

Cathepsin K knockout protects against cardiac dysfunction in diabetic mice

Double knockout of Akt2 and AMPK predisposes cardiac aging without affecting lifespan: Role of autophagy and mitophagy

Cardiomyocyte-specific Deletion of Endothelin Receptor A Rescues Aging-Associated Cardiac Hypertrophy and Contractile Dysfunction: Role of Autophagy

Abstract 186: Impaired Nucleocytoplasmic Shuttling and Activity of SIRT1 in Response to Ischemic Stress in the Senescent Heart

Ketogenic diet attenuates aging-associated myocardial remodeling and dysfunction in mice

Suppression of autophagy induces senescence in the heart

Chronic Akt Activation Accentuates Aging-Induced Cardiac Hypertrophy and Myocardial Contractile Dysfunction: Role of Autophagy

Abstract 14642: Cardiac-specific Transgenic Inhibition of NF-kB Attenuates Apoptosis and Remodeling in the Aging Heart

Akt2 ablation prolongs life span and improves myocardial contractile function with adaptive cardiac remodeling: role of Sirt1-mediated autophagy regulation

AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction.

Klotho deficiency causes cardiac ageing by impairing autophagic and activating apoptotic activity